W58P0522C0010
Definitive Contract
Overview
Government Description
COVID-19 Test Kits
Awardee
Awarding Agency
Funding Agency
National Interest Action
Place of Performance
Indianapolis, IN 46256 United States
Pricing
Fixed Price
Set Aside
None
Extent Competed
Full And Open Competition After Exclusion Of Sources
Related Opportunity
Analysis Notes
Amendment Since initial award the Potential End Date has been extended from 03/14/22 to 05/31/22.
Roche Diagnostics Corporation was awarded
Definitive Contract W58P0522C0010 (W58P05-22-C-0010)
for Covid-19 Test Kits
worth up to $569,500,000
by Joint PEO for Chemical, Biological, Radiological and Nuclear Defense
in January 2022.
The contract
has a duration of 4 months and
was awarded
through solicitation Rapid COVID-19 Antigen Test Kits
full & open
with
NAICS 325413 and
PSC 6515
via direct negotiation acquisition procedures with 20 bids received.
DOD Announcements
Jan 2022:
Roche Diagnostics Corp., Indianapolis, Indiana, was awarded a $340,000,000 firm-fixed-price contract for COVID-19 rapid antigen tests. Bids were solicited via the internet with 20 received. Work will be performed in Indianapolis, Indiana, with an estimated completion date of March 14, 2022. American Rescue Plan Act funds awarded in 2022 in the amount of $340,000,000 were obligated at the time of the award. U.S. Army Contracting Command, Aberdeen Proving Ground, Maryland, is the contracting activity (W58P05-22-C-0010). (Awarded Jan. 13, 2022)
Feb 2022: Roche Diagnostics Corp., Indianapolis, Indiana, was awarded a $212,500,000 modification (P00003) to contract W58P05-22-C-0010 for COVID-19 antigen test kits. Work will be performed in Indianapolis, Indiana, with an estimated completion date of May 31, 2022. American Rescue Plan Act funds awarded in fiscal 2022 in the amount of $212,500,000 were obligated at the time of the award. U.S. Army Contracting Command, Aberdeen Proving Ground, Maryland, is the contracting activity. (Awarded Feb. 16, 2022)
Feb 2022: Roche Diagnostics Corp., Indianapolis, Indiana, was awarded a $212,500,000 modification (P00003) to contract W58P05-22-C-0010 for COVID-19 antigen test kits. Work will be performed in Indianapolis, Indiana, with an estimated completion date of May 31, 2022. American Rescue Plan Act funds awarded in fiscal 2022 in the amount of $212,500,000 were obligated at the time of the award. U.S. Army Contracting Command, Aberdeen Proving Ground, Maryland, is the contracting activity. (Awarded Feb. 16, 2022)
Status
(Complete)
Last Modified 2/16/22
Period of Performance
1/13/22
Start Date
5/31/22
Current End Date
5/31/22
Potential End Date
Obligations
$569.5M
Total Obligated
$569.5M
Current Award
$569.5M
Potential Award
Award Hierarchy
Definitive Contract
W58P0522C0010
Subcontracts
Activity Timeline
Opportunity Lifecycle
Procurement history for W58P0522C0010
Transaction History
Modifications to W58P0522C0010
People
Suggested agency contacts for W58P0522C0010
Competition
Number of Bidders
20
Solicitation Procedures
Negotiated Proposal/Quote
Other Than Full and Open Competition
Urgency
Evaluated Preference
None
Commercial Item Acquisition
Commercial Item
Simplified Procedures for Commercial Items
No
Other Categorizations
Subcontracting Plan
Plan Not Required
Cost Accounting Standards
Exempt
Business Size Determination
Large Business
Defense Program
None
DoD Claimant Code
All Others Not Identifiable To Any Other Procurement Program
IT Commercial Item Category
Not Applicable
Awardee UEI
JDMDFEZBYH36
Awardee CAGE
51169
Agency Detail
Awarding Office
W58P05 W6QK ACC-APG NATICK
Funding Office
W56XNH
Created By
keith.l.mcpherson2.civ@army.mil
Last Modified By
keith.l.mcpherson2.civ@army.mil
Approved By
keith.l.mcpherson2.civ@army.mil
Legislative
Legislative Mandates
None Applicable
Performance District
IN-05
Senators
Todd Young
Mike Braun
Mike Braun
Representative
Victoria Spartz
Modified: 2/16/22